| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2801401901013 | 140190101 | TAGAMET F.C.TAB 200MG/TAB ΒΤx50(σε BLISTERS) | 4.16 | 4.36 | 06.01 |
| 05/2018 | 2801401902010 | 140190201 | TAGAMET F.C.TAB 400MG/TAB ΒΤx25 | 4.16 | 4.36 | 06.01 |
| 05/2018 | 2801401904014 | 140190401 | TAGAMET INJ.SOL 200MG/2ML AMP BTx10AMPx2ML | 2.29 | 2.40 | 3.30 |
For the treatment and the management of acid-reflux disorders (GERD), peptic ulcer disease, heartburn, and acid indigestion.
Cimetidine binds to an H<sub>2</sub>-receptor located on the basolateral membrane of the gastric parietal cell, blocking histamine effects. This competitive inhibition results in reduced gastric acid secretion and a reduction in gastric volume and acidity.
Symptoms of overdose include nausea, vomiting, diarrhea, increased saliva production, difficulty breathing, and a fast heartbeat.
Rapid 60-70%
2 hours
The principal route of excretion of cimetidine is the urine.